The Harvard Drug Group is recalling approximately 16,443 cartons of Doxycycline Hyclate Tablets (100 mg), a prescription antibiotic used to treat bacterial infections. Testing conducted at the end of the product's shelf life revealed that the tablets failed to dissolve at the required rate. If an antibiotic does not dissolve properly in the body, it may not be fully absorbed, which can lead to the medication being less effective than intended or failing to treat an infection entirely. The affected products were distributed nationwide in unit dose cartons of 30 or 50 tablets.
The drug failed dissolution specifications, which means the tablets may not break down and release the active medication into the bloodstream as required. This defect could result in a patient receiving an inadequate dose of the antibiotic, potentially allowing an infection to persist or worsen.
Healthcare consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.